| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |